pharma · Immunotherapy · Opioid Analgesic Adverse Reaction
Second Affiliated Hospital
Second Affiliated Hospital of Soochow University
Second Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Immunotherapy, Opioid Analgesic Adverse Reaction, Liver Cancer, Ulcerative Colitis (UC). NovaPharmaNews lin
CN HQ
103 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 103
- Programs
- 4
- Drugs
- 11
- Patents
- 0
Vedolizumab
Approved · mab · Ulcerative Colitis (UC)
Vedolizumab for Ulcerative Colitis (UC) is a Approved program (mab) at Second Affiliated Hospital of Soochow University with 1 ClinicalTrials.gov record(s).
Internal code SAHoWMU-CR2025-01-130
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Second Affiliated Hospital of Soochow University
- Phase
- Approved
- Modality
- mab
- Indication
- Ulcerative Colitis (UC)
- Status
- completed
- Trials
- 1